Kliniczne aspekty urazów i chorób mięśni: część 1 i 2 | Clinical Aspects of Muscle Injuries and Diseases: part 1 and 2

.tooltip { position: relative; cursor: pointer; text-decoration: none; border-bottom: 1px dashed rgba(0, 0, 0, 0.6); } .tooltip::before { content: attr(data-tooltip); position: absolute; top: -40px; /* Trochę niżej nad słowem */ left: 50%; /* Wyśrodkowanie */ transform: translateX(-50%); background-color: rgba(255, 255, 255, 0.9); color: #333; padding: 6px 12px; border-radius: 8px; white-space: nowrap; opacity: 0; visibility: hidden; transition: opacity 0.3s ease, visibility 0.3s ease; font-family: ‘Arial’, sans-serif; font-size: 14px; box-shadow: 0px 4px 8px rgba(0, 0, 0, 0.1); z-index: 10; } .tooltip:hover::before { opacity: 1; visibility: visible; } document.addEventListener(‘DOMContentLoaded’, function () { wordsToTooltip = { “Acute muscle injuries”: “Ostre urazy mięśni”, “Compartment syndrome”: “Zespół ciasnoty przedziałów powięziowych”, “Severe conditions”: “Poważne stany”, “Timely diagnosis”: “Diagnoza postawiona we właściwym czasie”, “Treatment”: “Leczenie”, “Prevent complications”: “Zapobiegać powikłaniom”, “Muscle strains”: “Naciągnięcia mięśni”, “Muscle tears”: “Naderwania mięśni”, “Quadriceps”: “Mięsień czworogłowy uda”, “Hamstrings”: “Mięśnie kulszowo-goleniowe”, “Calves”: “Mięśnie łydek”, “High-intensity activities”: “Aktywności o wysokiej intensywności”, “Sudden Force”: “Nagła siła”, “Overstretching”: “Nadmierne rozciągnięcie”, “Overuse”: “Przeciążenie”, “Inadequate Warm-Up”: “Niewystarczająca rozgrzewka”, “Decreased muscle elasticity”: “Zmniejszona elastyczność mięśni”, “Reduced flexibility”: “Ograniczona elastyczność”, “Rapid, forceful contractions”: “Nagłe, silne skurcze”, “Sprinting”: “Sprint”, “Lifting heavy objects”: “Podnoszenie ciężkich przedmiotów”, “Older individuals”: “Osoby starsze”, “Grade I”: “Stopień I”, “Minimal tearing of muscle fibers”: “Minimalne naderwanie włókien mięśniowych”, “Mild Strain”: “Łagodne naciągnięcie”, “Grade II”: “Stopień II”, “Moderate Strain”: “Umiarkowane naciągnięcie”, “Partial tear of the muscle fibers”: “Częściowe naderwanie włókien mięśniowych”, “Grade III”: “Stopień III”, “Severe Strain/Tear”: “Poważne naciągnięcie/naderwanie”, “Complete rupture of the muscle or its tendon”: “Całkowite zerwanie mięśnia lub jego ścięgna”, “Popping sensation”: “Odczucie „trzasku””, “Pain”: “Ból”, “Swelling and Bruising”: “Obrzęk i siniaki”, “Visible redness”: “Widoczne zaczerwienienie”, “Weakness and Loss of Function”: “Osłabienie i utrata funkcji”, “Difficulty moving the affected muscle”: “Trudność w poruszaniu dotkniętym mięśniem”, “Physical Examination”: “Badanie fizykalne”, “Palpation”: “Palpacja”, “Range of motion”: “Zakres ruchu”, “Manual muscle testing”: “Manualne testowanie mięśni”, “Muscle strength”: “Siła mięśni”, “Ultrasound”: “Ultrasonografia”, “Magnetic resonance imaging”: “Rezonans magnetyczny”, “RICE Protocol”: “Protokół RICE”, “Nonsteroidal anti-inflammatory drugs”: “Niesteroidowe leki przeciwzapalne (NLPZ)”, “Physical Therapy”: “Fizjoterapia”, “Strengthening exercises”: “Ćwiczenia wzmacniające”, “Stretching exercises”: “Ćwiczenia rozciągające”, “Surgical Intervention”: “Interwencja chirurgiczna”, “Rehabilitation program”: “Program rehabilitacyjny”, “Chronic Weakness”: “Przewlekłe osłabienie”, “Recurring Injuries”: “Nawracające urazy”, “Scar Tissue Formation”: “Tworzenie się blizny”, “Localized bleeding”: “Miejscowe krwawienie”, “Blunt Trauma”: “Tępy uraz”, “Contact Sports”: “Sporty kontaktowe”, “Motor vehicle accidents”: “Wypadki samochodowe”, “Localized trauma”: “Lokalny uraz”, “Ecchymosis”: “Wybroczyny”, “Muscle stiffness”: “Sztywność mięśni”, “Muscle Tightness”: “Napięcie mięśniowe”, “Myositis Ossificans”: “Kostniejące zapalenie mięśni”, “Tendinitis”: “Zapalenie ścięgien”, “Rotator cuff”: “Stożek rotatorów”, “Tennis elbow”: “Łokieć tenisisty”, “Achilles tendon”: “Ścięgno Achillesa”, “Repetitive Movements”: “Powtarzające się ruchy”, “Improper Technique”: “Nieprawidłowa technika”, “Tendinosis”: “Tendinoza”, “Tendon ruptures”: “Pęknięcia ścięgien”, “Chronic Overuse”: “Przewlekłe przeciążenie”, “Sudden, Sharp Pain”: “Nagły, ostry ból”, “Audible Snap or Pop”: “Słyszalny trzask lub pęknięcie”, “Visible deformity”: “Widoczna deformacja”, “Thompson test”: “Test Thompsona”, “Trauma or Crush Injuries”: “Urazy lub zmiażdżenia”, “Heatstroke”: “Udar cieplny”, “Dark urine”: “Ciemny mocz”, “Fatigue”: “Zmęczenie”, “Confusion”: “Dezorientacja”, “Nausea”: “Nudności”, “Elevated creatine kinase”: “Podwyższona kinaza kreatynowa”, “Serum”: “Surowica”, “fluid resuscitation”: “nawodnienie dożylne”, “Electrolyte Management”: “Zarządzanie elektrolitami”, “Dialysis”: “Dializa”, “Acute kidney injury”: “Ostra niewydolność nerek”, “Filter toxins from the blood”: “Filtrować toksyny z krwi”, “Prolonged rehabilitation”: “Przedłużona rehabilitacja”, “First-line treatment”: “Leczenie pierwszego wyboru”, “Chronic pain”: “Przewlekły ból”, “Tendon thickening”: “Pogrubienie ścięgien”, “Restricted movement”: “Ograniczony ruch”, “Tea-colored urine”: “Mocz koloru herbaty”, “Post-surgical complications”: “Powikłania pooperacyjne”, “Strain”: “Naciągnięcie”, “Prone”: “Leżenie na brzuchu”, “Injury”: “Uraz”, “Weakness”: “Osłabienie”, “Reduced strength”: “Zmniejszona siła”, ““Popping” or tearing sensation”: “Odczucie „trzasku” lub rozerwania”, “Swelling”: “Obrzęk”, “Redness”: “Zaczerwienienie”, “Bruising”: “Siniaki”, “Extent”: “Zakres”, “Tear”: “Naderwanie”, “Acute”: “Ostry”, “Muscle rupture”: “Zerwanie mięśnia”, “Blunt force trauma”: “Tępy uraz mechaniczny”, “Exacerbated”: “Pogorszony”, “Inflammation”: “Zapalenie”, “Tendon”: “Ścięgno”, “Excessive strain”: “Nadmierne naciągnięcie”, “Degenerative condition”: “Choroba zwyrodnieniowa”, “Debilitating”: “Wyniszczający”, “Diabetes”: “Cukrzyca”, “Cast”: “Gips”, “Brace”: “Orteza”, “Ruptures”: “Pęknięcia”, “Breakdown”: “Rozpad”, “Statins”: “Statyny”, “Muscle soreness”: “Ból mięśniowy”, “Bloodstream”: “Krwiobieg”, “Medical Conditions”: “Stany medyczne”, “Medications”: “Leki”, “Acute kidney failure”: “Ostra niewydolność nerek”, “Complications”: “Powikłania”, “X-linked recessive disorders”: “Choroby sprzężone z chromosomem X o recesywnym dziedziczeniu”, “Inheritance”: “Dziedziczenie”, “Family History”: “Wywiad rodzinny”, “Muscle fibers”: “Włókna mięśniowe”, “Degenerate”: “Degenerować”, “Dystrophin”: “Dystrofina”, “Onset age”: “Wiek wystąpienia”, “Severity”: “Nasilenie”, “Cardiac involvement”: “Zajęcie serca”, “Respiratory involvement”: “Zajęcie układu oddechowego”, “Elevated”: “Podwyższony”, “Absence”: “Brak”, “Heart failure”: “Niewydolność serca”, “Adolescence”: “Okres dojrzewania”, “Loss of Mobility”: “Utrata mobilności”, “Life expectancy”: “Przewidywana długość życia”, “Gender Prevalence”: “Przewaga płciowa”, “Fatigue”: “Zmęczenie”, “Skin Rashes”: “Wysypki skórne”, “Persistent”: “Utrzymujący się”, “Immunosuppressive treatment”: “Leczenie immunosupresyjne”, “Disease remission”: “Remisja choroby”, “Malignancies”: “Nowotwory złośliwe”, “Genetic Predisposition”: “Predyspozycja genetyczna”, “PTSD”: “Zespół stresu pourazowego (PTSD)”, “Serotonin”: “Serotonina”, “Norepinephrine”: “Noradrenalina”, “Ligaments”: “Więzadła”, “Tendons”: “Ścięgna”, ““Fibro fog””: “„Mgła mózgowa” (fibro fog)”, “Chronic fatigue”: “Przewlekłe zmęczenie”, “Sleep Disorders”: “Zaburzenia snu”, “Mental Health Issues”: “Problemy zdrowia psychicznego”, “Anxiety”: “Lęk”, “Chronic”: “Przewlekły”, “Autoimmune disorder”: “Choroba autoimmunologiczna”, “Thymomas”: “Grasiczaki”, “Drooping”: “Opadanie”, “Impaired”: “Upośledzony”, “Thymus gland”: “Grasica”, “Thymectomy”: “Tymektomia”, “Immunosuppressive Therapy”: “Terapia immunosupresyjna”, “Symptomatic treatments”: “Leczenie objawowe”, “Mortality rate”: “Wskaźnik śmiertelności”, “Acute tendinitis”: “Ostre zapalenie ścięgien”, “Inflammation”: “Zapalenie”, “Tenderness”: “Tkliwość”, “NSAIDs”: “Niesteroidowe leki przeciwzapalne (NLPZ)”, “Acute”: “Ostry”, “Degenerative”: “Zwyrodnieniowy”, “Surgical intervention”: “Interwencja chirurgiczna” }; // Normalize keys in the dictionary const normalizedWordsToTooltip = {}; for (const [key, value] of Object.entries(wordsToTooltip)) { const cleanedKey = key.replace(/(.*?)/g, ”).trim(); // Remove anything in parentheses normalizedWordsToTooltip[cleanedKey.toLowerCase()] = value; } function processNode(node) { if (node.nodeType === Node.TEXT_NODE && node.nodeValue.trim()) { let content = node.nodeValue; // Regex to match only the main words (ignores parentheses) const regex = new RegExp( `\b(${Object.keys(normalizedWordsToTooltip).join(‘|’)})\b`, ‘gi’ ); if (regex.test(content)) { const wrapper = document.createElement(‘span’); wrapper.innerHTML = content.replace(regex, (match) => { const tooltip = normalizedWordsToTooltip[match.toLowerCase().trim()]; return `${match}`; }); node.replaceWith(wrapper); } } else if (node.nodeType === Node.ELEMENT_NODE) { Array.from(node.childNodes).forEach(processNode); } } document.querySelectorAll(‘body *:not(script):not(style)’).forEach((element) => { Array.from(element.childNodes).forEach(processNode); }); });

Chronic Muscle Disorders

Chronic muscle disorders encompass a variety of conditions that result in prolonged muscle dysfunction, weakness, and pain. These disorders can be caused by genetic factors, autoimmune responses, or long-term overuse. This lesson covers some of the most common chronic muscle disorders, including muscular dystrophies, myositis, fibromyalgia, myasthenia gravis, and chronic tendinopathies.

Muscular Dystrophies (MDs)

Muscular dystrophies (MDs) are a group of inherited, progressive muscle disorders that result in muscle degeneration and weakness. The most well-known types include Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD). DMD is the most severe form, typically affecting young boys, while BMD is a milder form. Both types primarily affect skeletal muscles, but heart and respiratory muscles may also be involved as the disease progresses.

Etiology and Risk Factors

• Genetic Mutations: MDs are caused by mutations in the dystrophin gene, which is responsible for producing dystrophin, a protein crucial for maintaining the stability of muscle fibers.
• Inheritance: Both DMD and BMD are X-linked recessive disorders, meaning the defective gene is located on the X chromosome, primarily affecting males.
• Family History: A family history of muscular dystrophy significantly increases the risk of inheriting the disorder.

Pathophysiology

As muscle fibers degenerate, they are replaced by fat and fibrotic tissue, which leads to progressive weakness and loss of function.

• Duchenne Muscular Dystrophy: The absence of dystrophin leads to the breakdown and death of muscle fibers, causing rapid and severe muscle deterioration.
• Becker Muscular Dystrophy: Some dystrophin is produced, which leads to a milder and slower progression of symptoms.

Duchenne vs. Becker Muscular Dystrophy

Feature	Duchenne Muscular Dystrophy (DMD)	Becker Muscular Dystrophy (BMD)
Onset Age	Early childhood (usually before 5 years)	Later childhood to early adulthood
Dystrophin Production	Absent	Reduced or abnormal
Severity	Severe	Milder, slower progression
Ambulation Loss	By early teens	May retain ability to walk into adulthood
Cardiac Involvement	Common	Common but less severe
Respiratory Involvement	Severe	Possible, but typically less severe

Clinical Manifestations

• Progressive Muscle Weakness: Typically starts in the lower extremities and pelvic muscles and later spreads to the upper limbs, neck, and respiratory muscles.
• Pseudohypertrophy: Calf muscles may appear enlarged due to the accumulation of fat and fibrotic tissue.
• Gait Abnormalities: Waddling gait or toe-walking, frequent falls.
• Cardiorespiratory Complications: Respiratory muscle weakness, respiratory failure, and cardiomyopathy.
• Loss of Ambulation: DMD patients often lose the ability to walk by adolescence, while BMD patients may retain some mobility into adulthood.

Diagnostic Approach

• Genetic Testing: Identifies mutations in the dystrophin gene, confirming the diagnosis.
• Elevated Creatine Kinase (CK) Levels: CK levels are significantly elevated due to ongoing muscle damage.
• Muscle Biopsy: Shows the absence or reduction of dystrophin in muscle tissue.

Treatment

• Corticosteroids: Medications like prednisone can slow the progression of muscle degeneration.
• Physical Therapy: Helps maintain mobility, strengthen muscles, and reduce contractures.
• Gene Therapy: Emerging treatments aim to correct the underlying genetic mutations.
• Assistive Devices: Wheelchairs, ventilatory support, and other assistive devices as the disease progresses.

Complications

• Respiratory Failure: Weakening of respiratory muscles can lead to respiratory complications.
• Cardiomyopathy: Progressive heart muscle weakening can lead to heart failure.
• Loss of Mobility: Most patients with DMD lose the ability to walk by adolescence.

Prognosis for Muscular Dystrophies (MDs)

• Becker Muscular Dystrophy (BMD): The prognosis is more favorable, with patients often living into middle or late adulthood. Disease progression is slower, and mobility can be retained well into adulthood. However, cardiac issues may significantly impact long-term outcomes.
• Duchenne Muscular Dystrophy (DMD): Life expectancy has improved with advanced cardiac and respiratory care, but patients often live into their 20s or 30s. The progression is severe, with loss of ambulation occurring in early adolescence and significant respiratory and cardiac complications.

Myositis (Polymyositis and Dermatomyositis)

Myositis refers to a group of chronic, autoimmune disorders that cause inflammation and weakness of the muscles. The two main types are Polymyositis (PM), which primarily affects the muscles, and Dermatomyositis (DM), which affects both muscles and the skin.

Etiology and Risk Factors

• Autoimmune Response: Caused by the immune system mistakenly attacking muscle fibers, leading to chronic inflammation.
• Environmental Triggers: Infections, medications, or environmental factors may trigger myositis in genetically susceptible individuals.
• Gender: More common in women, especially dermatomyositis.

Pathophysiology

• Polymyositis (PM): Involves inflammation primarily of the proximal muscles, such as the shoulders, hips, and neck.
• Dermatomyositis (DM): Similar to PM but includes characteristic skin manifestations, such as a heliotrope rash around the eyes and Gottron’s papules on the knuckles.
• Inflammation results from immune cell infiltration of muscle fibers and, in DM, immune complex deposition in blood vessels.

Polymyositis vs. Dermatomyositis

Feature	Polymyositis (PM)	Dermatomyositis (DM)
Primary Muscle Involvement	Proximal muscles (shoulders, hips, neck)	Proximal muscles + skin involvement
Skin Involvement	None	Heliotrope rash, Gottron’s papules
Gender Prevalence	More common in females	More common in females
Immune Mechanism	T-cell mediated muscle inflammation	B-cell and immune complex-mediated inflammation
Treatment	Corticosteroids, immunosuppressive drugs	Corticosteroids, immunosuppressive drugs, sun protection

Clinical Manifestations

• Symmetrical Muscle Weakness: Involves shoulders, hips, and neck, affecting both sides of the body.
• Skin Rashes in Dermatomyositis: Reddish-purple rash around the eyes (heliotrope rash) and scaly eruptions on the knuckles (Gottron’s papules).
• Fatigue: Due to chronic muscle inflammation.
• Dysphagia: Difficulty swallowing due to involvement of esophageal muscles.

Diagnostic Approach

• Elevated Muscle Enzymes: CK and aldolase levels are typically elevated.
• Electromyography (EMG): Detects abnormal electrical activity in inflamed muscles.
• Muscle Biopsy: Confirms inflammation and immune cell infiltration in muscle tissue.

Treatment

• Corticosteroids: High doses of steroids like prednisone are the first-line treatment.
• Immunosuppressive Drugs: Methotrexate or azathioprine for long-term management.
• Physical Therapy: Helps maintain muscle strength and prevent contractures.
• Sun Protection: Avoiding sun exposure is crucial for DM patients.

Complications

• Chronic Muscle Weakness: Persistent weakness due to ongoing inflammation.
• Skin Complications: In DM, persistent skin rashes can lead to scarring or pigmentation changes.
• Dysphagia and Aspiration: Swallowing difficulties can lead to aspiration pneumonia.

Prognosis

• Polymyositis: The prognosis varies widely. With appropriate immunosuppressive treatment, about 60-80% of patients experience significant improvement or disease remission. However, muscle weakness may persist in some individuals, and approximately 20% may develop severe complications, such as respiratory failure or cardiac involvement.
• Dermatomyositis: The prognosis depends on disease severity and the presence of internal malignancies. With treatment, 70-90% of patients improve significantly, but about 30% may experience chronic muscle weakness. There is also an increased risk of developing cancer, with up to 15-25% of adult patients diagnosed with associated malignancies. Regular cancer screenings are recommended as part of ongoing care.

Fibromyalgia

Fibromyalgia is a chronic pain syndrome characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and cognitive issues. It is classified as a central sensitization syndrome, where the central nervous system processes pain signals abnormally, amplifying the sensation of pain.

Etiology and Risk Factors

• Central Sensitization: Resulting from abnormal pain processing in the brain and spinal cord.
• Genetic Predisposition: A family history of fibromyalgia or other chronic pain syndromes.
• Stress and Trauma: Physical (e.g., car accidents) or emotional trauma (e.g., PTSD).
• Gender: More common in women.

Pathophysiology

Fibromyalgia involves dysfunctional pain processing within the central nervous system, resulting in increased sensitivity to pain (allodynia). Altered levels of neurotransmitters like serotonin, norepinephrine, and substance P contribute to heightened pain response.

Clinical Manifestations

• Widespread Pain: Chronic, diffuse pain affecting muscles, ligaments, and tendons.
• Tender Points: Specific areas unusually sensitive to pressure.
• Fatigue: Persistent tiredness not relieved by rest.
• Sleep Disturbances: Difficulty falling asleep, staying asleep, or waking up unrefreshed.
• Cognitive Dysfunction: “Fibro fog” involving difficulties with memory, concentration, and thinking.
• Mood Disorders: Depression and anxiety are common.

Diagnostic Approach

• Clinical Diagnosis: Based on widespread pain lasting more than three months and tender points.
• Exclusion of Other Conditions: Blood tests and imaging to rule out other causes.

Treatment

• Medications: Antidepressants like duloxetine or amitriptyline and anticonvulsants like pregabalin.
• Cognitive Behavioral Therapy (CBT): Helps manage chronic pain through coping mechanisms.
• Exercise: Low-impact aerobic activities like swimming or walking.
• Multidisciplinary Approach: Physical therapy, mental health support, and pain management.

Complications

• Chronic Fatigue: Persistent fatigue can significantly affect quality of life.
• Sleep Disorders: Ongoing sleep disturbances can lead to other health issues.
• Mental Health Issues: Increased risk of depression and anxiety due to chronic pain.

Prognosis for Fibromyalgia

• Chronic but Manageable: While fibromyalgia is a lifelong condition, it does not cause damage to muscles or organs. The prognosis is influenced by effective management of pain and other symptoms.

Myasthenia Gravis (MG)

Myasthenia gravis (MG) is a chronic autoimmune disorder that causes weakness and rapid fatigue of voluntary muscles. It is caused by the production of autoantibodies that block or destroy acetylcholine receptors at the neuromuscular junction.

Etiology and Risk Factors

• Autoimmune Disease: Antibodies attack acetylcholine receptors at the neuromuscular junction.
• Thymus Abnormalities: Thymomas or other abnormalities are common in MG patients.
• Gender and Age: More common in women under 40 and men over 60.

Pathophysiology

Autoantibodies bind to acetylcholine receptors, reducing the number of functional receptors and impairing nerve signal transmission to muscles. This results in muscle weakness that worsens with use and improves with rest.

Clinical Manifestations

• Muscle Weakness: Worsens with activity and improves with rest; affects muscles responsible for eye movement, facial expression, chewing, swallowing, and limb movement.
• Ptosis and Diplopia: Drooping of the eyelids (ptosis) and double vision (diplopia).
• Bulbar Symptoms: Difficulty speaking, chewing, and swallowing.
• Respiratory Muscle Weakness: In severe cases, can lead to myasthenic crisis.

Diagnostic Approach

• Blood Tests: Detection of acetylcholine receptor antibodies or anti-MuSK antibodies.
• Electromyography (EMG): Detects impaired neuromuscular transmission.
• Edrophonium Test: Improvement of muscle strength with edrophonium administration.
• CT or MRI of the Chest: To check for thymomas.

Treatment

• Acetylcholinesterase Inhibitors: Pyridostigmine increases acetylcholine at the neuromuscular junction.
• Immunosuppressive Therapy: Corticosteroids and other immunosuppressive drugs.
• Thymectomy: Surgical removal of the thymus gland.
• Plasmapheresis and IVIg: Used in severe cases to remove or neutralize autoantibodies.

Complications

• Myasthenic Crisis: Severe respiratory muscle weakness requiring emergency intervention.
• Respiratory Infections: Weakened respiratory muscles can lead to increased risk of infections.
• Ocular Complications: Persistent ptosis and double vision affecting daily activities.

Prognosis

• General Prognosis: Myasthenia Gravis (MG) has a variable prognosis. With advancements in treatment, most patients can achieve good symptom control and lead relatively normal lives. Approximately 90% of patients experience significant improvement with immunosuppressive therapy and symptomatic treatments like acetylcholinesterase inhibitors.
• Severe Cases: In severe or poorly managed cases, there is a risk of myasthenic crisis, which can be life-threatening and requires immediate medical intervention. The mortality rate from myasthenic crisis has significantly decreased with modern care, now below 5%.
• Long-Term Outcomes: About 20-30% of patients may develop permanent muscle weakness despite treatment. Regular monitoring and long-term management are crucial to prevent complications, particularly respiratory and cardiac issues.

Chronic Tendinopathies

Chronic tendinopathies refer to long-term degeneration of tendons due to overuse, mechanical stress, or repetitive trauma. Unlike acute tendinitis, which is characterized by inflammation, chronic tendinopathies involve tendinosis, where there is degeneration of the tendon’s collagen fibers without significant inflammation.

Etiology and Risk Factors

• Overuse: Repetitive motion or excessive strain on a tendon without adequate recovery time leads to tendon degeneration.
• Age: Tendon elasticity decreases with age, making older individuals more prone to tendinopathies.
• Poor Biomechanics: Improper technique in sports or work-related activities can overload tendons.
• Previous Injury: A history of tendinitis or tendon injury increases the likelihood of developing tendinopathy.

Pathophysiology

In chronic tendinopathies, repetitive microtrauma to the tendon leads to the breakdown of collagen fibers, resulting in degenerative changes rather than inflammation. Tendons lose their normal structure and strength, making them prone to further injury.

Chronic Tendinopathies vs. Tendinitis

Feature	Chronic Tendinopathies	Tendinitis
Nature of Disorder	Degenerative (tendinosis)	Inflammatory
Symptoms	Chronic pain, thickening of tendon	Acute pain, localized tenderness
Inflammation	Minimal to none	Significant
Treatment	Rest, rehabilitation, shockwave therapy, surgery	NSAIDs, rest, physical therapy
Duration	Long-term	Short-term (acute)

Clinical Manifestations

• Chronic Pain: Persistent pain localized to the affected tendon, which often worsens with movement or activity.
• Decreased Range of Motion: Tendon stiffness can limit joint mobility, making daily activities difficult.
• Thickening of the Tendon: Degenerative changes can cause the tendon to become thickened and less flexible.

Diagnostic Approach

• Ultrasound/MRI: These imaging techniques are used to visualize degenerative changes in tendons and assess the extent of damage.
• Physical Examination: Evaluates pain, swelling, and reduced mobility of the affected joint or tendon.

Treatment

• Rest and Rehabilitation: Avoiding activities that aggravate the condition and focusing on rest and rehabilitation.
• Physical Therapy: Strengthening the surrounding muscles to reduce stress on the tendons and improve joint function.
• Anti-inflammatory Medications: Nonsteroidal anti-inflammatory drugs (NSAIDs) can provide temporary relief but are less effective in treating the degenerative nature of tendinosis.
• Shockwave Therapy: A non-invasive treatment that uses acoustic waves to stimulate healing in chronic tendinopathies.
• Surgery: In severe cases, surgical intervention may be required to remove damaged tissue and stimulate tendon healing.

Complications

• Chronic Pain: Persistent pain that can significantly affect daily activities.
• Reduced Mobility: Tendon stiffness can lead to reduced joint function and limited range of motion.
• Tendon Rupture: Severe degeneration may lead to a complete rupture, requiring surgical repair.

Prognosis for Chronic Tendinopathies

• Long-Term Management: Recovery can be prolonged, with many patients requiring months of rehabilitation. While pain and function often improve, some individuals may experience persistent symptoms or require surgical intervention.